Carbetocin is NOT contraindicated in asthmatic patients
Based on available evidence, carbetocin does not have asthma listed as a contraindication and can be safely used in patients with asthma. The primary concerns with carbetocin relate to severe allergic reactions to platinum-containing compounds and bone marrow suppression—neither of which are relevant to asthma 1.
Key Evidence Points
No Respiratory Contraindications in Guidelines
The most recent Enhanced Recovery After Surgery (ERAS) guidelines for cesarean delivery (2025) recommend carbetocin as an effective uterotonic agent without any mention of asthma as a contraindication 2. The guidelines note that carbetocin's undesirable effects include nausea, tachycardia, hypotension, and water retention—but bronchospasm is NOT listed as a side effect of carbetocin 2.
Distinction from Prostaglandins
This is a critical distinction: Bronchospasm is specifically associated with prostaglandin uterotonics (such as carboprost), NOT with carbetocin 2. Carbetocin is an oxytocin analog, not a prostaglandin, and therefore does not carry the same respiratory risks.
Clinical Trial Safety Data
Multiple systematic reviews and meta-analyses of carbetocin use have not identified respiratory complications or bronchospasm as adverse events:
- A 2021 meta-analysis of 17 RCTs involving 32,702 women found no significant respiratory adverse effects with carbetocin 3
- A 2016 systematic review comparing carbetocin with other uterotonics showed a favorable safety profile without respiratory complications 4
- A large 2026 retrospective cohort study of 6,235 births found carbetocin to be safe and effective without respiratory adverse events 5
Important Caveat: NSAIDs and Asthma
While carbetocin itself is safe in asthma, be cautious with NSAIDs (such as ketorolac) that are often given concurrently for postpartum analgesia. NSAIDs should be used with caution in patients with asthma, especially those with nasal polyps or recurrent sinusitis, as they can trigger aspirin-exacerbated respiratory disease 6. The prevalence of aspirin-exacerbated respiratory disease is up to 21% in adults with asthma 6.
Clinical Bottom Line
Carbetocin can be safely administered to asthmatic patients for prevention of postpartum hemorrhage. The medication that requires caution in asthmatics during obstetric care is carboprost (a prostaglandin), not carbetocin. Ensure proper asthma control perioperatively and exercise appropriate caution with concurrent NSAID administration for analgesia.